MSWA has allocated further funding to an important Curtin University study investigating links between MS and diet, with a new focus on how red meat and omega-3 fatty acids impact early progression of the disease.
Filter News Articles
20 December 2019
Microscope on microbiome research
They say the gut is the second brain, but is gut bacteria disrupting the balance between the gastrointestinal system and the brain for those living with Parkinson’s disease (PD)?
18 December 2019
WASO musicians relax at MSWA’s SensAtion Gallery
WASO musicians recently came down to MSWA’s SensAtion Gallery to experience our multi-sensory exhibition for themselves.
12 December 2019
Translating research into practice
MSWA adds Edith Cowan University to its list of local research partnerships continuing our focus on funding unique, outcomes-driven research projects locally, nationally and globally.
10 December 2019
Associate Professor Jenny Rodger talks about The SensAtion Gallery
All roads lead to the brain.
Hear Associate Professor Jenny Rodger speak about the importance of the brain for processing our senses and for everyday life at MSWA's latest event: The SensAtion Gallery.
27 November 2019
New research set to improve outcomes for people living with Alzheimer’s disease
MSWA is delighted to announce the funding of a new pilot clinical trial of a drug that aims to prevent further memory loss in people living with Alzheimer’s disease.
26 November 2019
SensAtional new MSWA event
MSWA has opened the doors to a new event, The SensAtion Gallery, an interactive multi-sensory art gallery which is currently being held at the Queens Riverside Precinct.
14 November 2019
First ever secondary progressive MS treatment approved in Australia
11 November 2019
MSWA welcomes Jemma Barsby to Perth
Jemma Barsby, a young Australian cricketer diagnosed with multiple sclerosis, shares her personal story.
29 October 2019
Australian Government approves amended PBS listing of two MS medications for children with RRMS
Two MS medications for children with relapsing remitting MS (RRMS) will be amended on the Pharmaceutical Benefits Scheme (PBS), from 1 November 2019.